Diagnosing Lyme disease if bull’s eye rash is present – NICE quality standard
Doctors should be diagnosing Lyme disease if bull’s eye rash is present, says NICE as it launches its Lyme disease NICE quality standard consultation.
The...
The Topol Review: Preparing the healthcare workforce to deliver the digital future
The Topol Review: Preparing the healthcare workforce to deliver the digital future has been published and it makes recommendations to enable NHS staff to...
Research into chemotherapy dose intensity and breast cancer
New research into chemotherapy dose intensity and breast cancer finds that giving chemotherapy drugs every two weeks instead of the usual every three weeks...
Competition enforcement contributes to affordable and innovative medicines
The European Commission has published a report showing that active competition law enforcement, at EU and national level, in the pharmaceutical sector contributes to...
Origins of depression brought into focus in large-scale gene study
The origins of depression have been brought into focus in a large-scale gene study, involving more than two million people. Hundreds of genes have been newly-linked...
Mapping oesophageal cancer genes leads to new drug targets
Mutations that cause oesophageal adenocarcinoma (OAC) have been mapped in unprecedented detail – unveiling that many could be targeted by drugs currently in trials...
Response to new GP contract
With the announcement of the new GP contract negotiated by the BMA and NHS England, there has been a slew of responses.
Professor Helen Stokes-Lampard,...
Smart Peak Flow detects asthma exacerbations before patients feel it
Smart Peak Flow - the medically certified asthma monitoring device that plugs into a the headphone jack of a smartphone. The World Health Organisation estimates...
Is pharma prepared for future NHS commissioning?
What’s the future for NHS commissioning and is pharma prepared? The NHS has had commissioning since 1991 but it has definitely failed to thrive and,...
NHS App begins public rollout
After successful private testing with more than 3,000 patients across 30 GP practices in England, the NHS App has started its public rollout. The NHS...
Latest articles
Novo Nordisk presents oral semaglitude data at ENDO
Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Pf Award Winners on the positive patient outcomes that come from working together
The winners of the Joint Working Pf Award 2018, Senior Coloplast Care Nurse Ruth Christer and NHS Partnership Manager, Coloplast, Jonathan Walker, on the...
Detecting and managing atrial fibrillation
The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...
Popular articles
Detecting and managing atrial fibrillation
The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...
Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab)
Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab) in early or locally advanced HER2-positive breast cancer. Samsung Bioepis has announced the findings of...
The future of genomics and precision medicine
How is the use of genomics data enhancing our medical understanding and what does this mean for the future of precision medicine? Genomics is one of...
Novo Nordisk presents oral semaglitude data at ENDO
Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Addressing the skills shortage in life sciences
How can collaboration help to fill the skills shortage gap to ensure that the UK can compete in the global future of life sciences? The...